Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sargramostim for AZT-induced neutropenia in pediatric HIV
NCT00002263Phase 2Completed
- Sponsor
- Sandoz
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sargramostim in neutropenia, sponsored by Sandoz. Primary endpoint: Granulocyte count. Status: completed.
02
Drugs
sargramostim
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT00002263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002263.